Skin melanoma deaths within 1 or 3 years from diagnosis in Europe

Lidia Sacchetto*, Stefano Rosso, Harry Comber, Christine Bouchardy, Paolo Broganelli, Jaume Galceran, Monika Hackl, Alexander Katalinic, Marieke Louwman, Trude E. Robsahm, Laufey Tryggvadottir, Rosario Tumino, Elizabeth Van Eycken, Paul M. Walsh, Vesna Zadnik, Roberto Zanetti

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

The steep increase in incidence of cutaneous malignant melanoma in white populations mainly applies to thin lesions with good survival suggesting overdiagnosis. Based on population-based cancer registries (CRs), we have investigated changes in aggressive melanoma, selecting only cases who died within 1 or 3 years after diagnosis in 11 European countries between 1995 and 2012. Trends in fatal cases were analysed by period of diagnosis, sex, tumour thickness, histologic subtype of the lesion, tumour site and CR with a multivariate generalised linear mixed effects model, where geographical area was considered as a random effect. We collected data on 123 360 invasive melanomas, with 5133 fatal cases at 1 year (4%) and 12 330 (10%) at 3 years. The number of fatal cases showed a 16% decrease at 1 year and 8% at 3 years between the first (1995-2000) and the last (2007-2012) period. The highest proportion of fatal cases was seen for men, older age (≥65 years), thick lesions (>1 mm), nodular melanoma, melanoma on the trunk and for poorly documented cases, lacking information about thickness and histologic subtype. The mixed-effects model showed a remarkable variability among European countries. The majority of registries showed a decreasing trend in fatal cases, but a few registries showed an opposite pattern. Trends in fatal melanoma cases, highlighting real changes in risk not related to overdiagnosis, showed a decrease in most European countries, with a few exceptions. Stronger efforts for early detection could lead to a more efficient treatment of melanoma in general.

OriginalspracheEnglisch
ZeitschriftInternational Journal of Cancer
Jahrgang148
Ausgabenummer12
Seiten (von - bis)2898-2905
Seitenumfang8
ISSN0020-7136
DOIs
PublikationsstatusVeröffentlicht - 15.06.2021

Strategische Forschungsbereiche und Zentren

  • Profilbereich: Zentrum für Bevölkerungsmedizin und Versorgungsforschung (ZBV)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Skin melanoma deaths within 1 or 3 years from diagnosis in Europe“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren